Unicycive Therapeutics (UNCY) Non-Current Assets (2021 - 2026)
Unicycive Therapeutics (UNCY) recorded Non-Current Assets of $709,000 in Q2 2026, up 51.2% from $469,000 a year earlier but down 17.7% from the prior quarter.
Powered by 
Analysis
Unicycive Therapeutics (UNCY) Non-Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025, Unicycive Therapeutics reported Non-Current Assets of $174,000, down 75.8% from FY2024.
- Annual Non-Current Assets has a four-year compound annual growth rate of -15.0% (FY2021 to FY2025).
- Across earlier years, Non-Current Assets came in at $720,000 in FY2024 (-9.1%), $792,000 in FY2023 (+355.2%), $174,000 in FY2022 (-47.7%) and $333,000 in FY2021.
- Quarterly Non-Current Assets has ranged from $174,000 in Q4 2022 to $1.02 million in Q1 2023 over the past five years.
- On a year-over-year basis, Non-Current Assets rose in two of the last eight quarters, with an average decline of 12.4%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 355.2% in Q4 2023, against a decline of 75.8% in Q4 2025 at the low end.
- Per Business Quant, the preceding three quarters came in at $861,000 (Q1 2026), $174,000 (Q4 2025) and $324,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 77.61 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 141.07 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 101.45 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 125.00 Mn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 94.68 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 87.87 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 60.68 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 35.42 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 159.77 Bn |
| 10 | Unicycive Therapeutics | 106.32 Mn | -93.65 Mn | - | 709,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 709,000.00 |
| Mar 31, 2026 | 861,000.00 |
| Dec 31, 2025 | 174,000.00 |
| Sep 30, 2025 | 324,000.00 |
| Jun 30, 2025 | 469,000.00 |
| Mar 31, 2025 | 601,000.00 |
| Dec 31, 2024 | 720,000.00 |
| Sep 30, 2024 | 833,000.00 |
| Jun 30, 2024 | 647,000.00 |
| Mar 31, 2024 | 709,000.00 |
| Dec 31, 2023 | 792,000.00 |
| Sep 30, 2023 | 873,000.00 |
| Jun 30, 2023 | 953,000.00 |
| Mar 31, 2023 | 1.02 Mn |
| Dec 31, 2022 | 174,000.00 |
| Sep 30, 2022 | 215,000.00 |
| Jun 30, 2022 | 256,000.00 |
| Mar 31, 2022 | 296,000.00 |
| Dec 31, 2021 | 333,000.00 |
API Access
Unicycive Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=UNCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "UNCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=UNCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();